JPRN-UMIN000004953已完成未知
A randomized open study to compare the efficacy and safety of GLP-1 analogue (Liraglutide) versus DPP-4 inhibitor (Vildagliptin) in patients with Type 2 Diabetes. - ERA-DM Chapter 2
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science0 个研究点目标入组 80 人开始时间: 2011年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Hypersensitivity to or contraindication of Liraglutide and Vildagliptin 2)None Type 2 diabetes 3)Medical history and/or complication of Diabetic ketoacidosis 4)Medical history and/or complication of severe hypoglycemia 5)Insulin treatment within 4 weeks prior to the study 6)Treatment with Liraglutide or Vildagliptin within 12 weeks prior to the study 7)New or Change treatment with Glucocorticoid 8)Unstable glycemic contol 9)Ccr(Cockcraft) < 30mL/h or sCre > 2.5 mg/dL(male), > 2.0mg/dL (Female) 10)AST or ALT >=2.5 time of institutional upper normal limit 11)Uncontrolled hypertension(systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 12)Severe health problems not suitable for the study 13)Pregnant or lactating women
研究者
相似试验
尚未招募
不适用
To know the efficacy of two unani formulations in deranged lipid levelsCTRI/2022/09/045383Department of moalajat Ajmal khan Tibbiya college Aligarh Muslim university Aligarh
尚未招募
3 期
An open randomised Comparative Study of 2 drug Vyoshadi Churna and Loha Bhasma in the Management of Pandu Roga with Special Reference to Iron Deficiency AnaemiaCTRI/2024/05/067409APMs Ayurved Mahavidyalaya
进行中（未招募）
1 期
Open, comparative, randomized study on the efficacy, safety and bioavailability of highly concentrated inhaled epinephrine (4 mg L-epinephrine / ml, Infectokrupp® Inhal) versus epinephrine autoinjector application (Fastjekt® Junior) in infants with acute anaphylactic reaction during a food provocatioFood allergyEUCTR2014-000097-19-DECharité Universitätsmedizin Berlin40
进行中（未招募）
不适用
Open randomized study to evaluate the efficacy of i.v. iron support (ferrum gluconate, 125 mg i.v. infusion weekly for 6 weeks) in primary solid tumour patients (breast, lung, colon-rectum and gynecological) treated with darbepoetin alfa (150 mcg once weekly subcutaneous for 12 weeks)for neoplastic chemotherapy related anaemia.EUCTR2004-002176-42-ITDOMPE' BIOTEC420
进行中（未招募）
1 期
Randomized not blinded clinical trial to compare two sequences oftreatment: STZ-5FU followed by everolimus or everolimus followed by STZ-5FU upon progression in advanced progressive pancreatic neuroendocrinetumors (SEQTOR study)advanced progressive pNETsMedDRA version: 17.1Level: PTClassification code 10067517Term: Pancreatic neuroendocrine tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.1Level: PTClassification code 10068909Term: Pancreatic neuroendocrine tumour metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000726-66-FRGrupo Español de Tumores Neuroendocrinos (GETNE)180